Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients

Transplantation

Volumn 86, Issue 3, 2008, Pages 384-390

  Fuggle, Susan V ^a,b,c   Martin, Susan ^d  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UK Transplant   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

HLA antibody detection; Renal transplantation; Sensitized patients

Indexed keywords

FLUORESCENT DYE; HLA ANTIBODY; ALLOANTIBODY; HLA ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; KIDNEY TRANSPLANTATION; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL; SENSITIZATION; BLOOD; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; METHODOLOGY; PATIENT SELECTION; TRANSPLANTATION;

ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT DYES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; KIDNEY TRANSPLANTATION; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT;

EID: 52049121689     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817c90f5     Document Type: Article

References (42)

1. Van den Watering L, Hermans J, Witvliet M, et al. HLA and red blood cell immunization after filtered and buffy coat transfusion in cardiac surgery: A randomized controlled trial. Transfusion 2003; 43: 765.
2. Fuggle SV, Belger MA, Johnson RJ, et al. A new national scheme for the allocation of adult kidneys in the UK. In: Cecka JM, Terasaki P, eds. Clinical transplants 1998. Los Angeles, UCLA Tissue Typing Laboratory 1999, p 107.
3. Fuggle SV, MartinS. Toward performing transplantationinhighly sensitised patients. Transplantation 2004; 78: 186.
4. British Transplantation Society and British Society for Histocompatibility and Immunogenetics. Guidelines for the detection and characterisation of clinically relevant antibodies in solid organ transplantation. ISBN: 0-954221-6-4.
5. Bray RA, Nolan JDL, LarsenC, etal. Transplanting the highly sensitized patient: The Emory algorithm. Am J Transplant 2006; 6: 2307.
6. Class FHJ, Witvliet MD, Duquesnoy RJ, etal. The acceptable mismatch programme as a fast tool for identifying highly sensitized patients awaiting cadaveric kidney transplantation: Short waiting time and excellent graft outcome. Transplantation 2004; 78: 190.
7. Worthington JE, Langton A, Liggett H, et al. A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting transplantation. Transpl Int 1998; 11(suppl 1): S372.
8. Gebel HM, Bray RA. Sensitization and sensitivity. Defining the unsensitized patient. Transplantation 2000; 69: 1370.
9. Gebel HM, Bray RA. Laboratory assessment of HLA antibodies circa 2006: Making sense of sensitivity. Transplant Rev 2006; 189.
10. Susskind B. Methods for histocompatibility testing in the early 21st century. Curr Opin Organ Transplant 2007; 12: 393.
11. Martin S, Claas F. Antibodies and crossmatching for transplantation. In: Dyer PA, MiddletonD,eds. Histocompatibility testing - A practical approach. Oxford, IRL Press 1993, p 81.
12. Ting A, Morris PJ. Reactivity of autolymphocytotoxic antibodies from dialysis patients with lymphocytes from chronic lymphocytic leukaemia (CLL) patients. Transplantation 1978; 25: 31.
13. Ting A, Morris PJ. Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens 1983; 21: 219.
14. Wahrmann M, Exner M, Schillinger M, et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006; 6: 1033.
15. Smith JD, Hamour IM, Banner NR, et al. C4d fixing, Luminex binding antibodies - A new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
16. Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation. Transplant Proc 1983; 15: 1939.
17. Harmer AW, Sutton M, Bayne A, et al. A highly sensitive rapid screening method for the detection of antibodies directed against HLA Class I and Class II antigens. Transpl Int 1993; 6: 277.
18. Horsburgh T, Martin S, Robson AJ. The application of flow cytometry to histocompatibility testing. Transpl Immunol 2000; 8: 3.
19. Buelow R, Mercier I, Glanville L, et al. Detection of panelreactive anti-HLA classI antibodiesby enzyme-linked immunosorbent assay orlymphocytotoxicity. Results of a blinded multicenter study. Hum Immunol 1995; 44: 1.
20. Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies - An alternative to panel studies by lymphocytotoxicity. Transplantation 1992; 55: 192.
21. Wang G, Tarsitanic C, Takemura S, et al. ELISA assay for the detection of specific antibodies to classI HLA antigens in transplant patients with panel reactive antibodies. Hum Immunol 1996; 49: 109.
22. Worthington JE, Robson AJ, SheldonS, et al. Acomparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies. Hum Immunol 2001; 62: 1178.
23. Pei R, Wang C, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry.Hum Immunol1998; 59: 313.
24. Pei R, Lee J-H, Shih N-J, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75: 43.
25. Vaidya S, Partlow D, Susskind B, et al. Predication of crossmatch outcome of highly sensitised patients by single and/or multiple antigen bead luminex assay. Transplantation 2006; 82: 1524.
26. Higgins R, Hathaway M, LoweD.Blood levelsofdonor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007; 84: 876.
27. Zhang Q, Liang LW, Gjertson DW, et al. Development of posttrans-plant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction. Transplantation 2005; 79: 591.
28. Mizutani K, Terasaki P, Hamdani E, et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007; 7: 1027.
29. El-Awar N, Lee JH, Tarsitani C, et al. HLA class I epitopes: Recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007; 68: 170.
30. Doxiadis NII, Witvliet MD, Haasnoot GW, et al. The virtual PRA (panel reactive antibody value): And excellent tool to predict the chance to find a crossmatch negative donor. Tissue Antigens 2007; 69: 373.
31. Suzzkind B. Methods for histocmpatibility testing in the early 21st century. Curr Opin Organ Transplant 2007;12: 393.
32. Fuggle SV, Johnson RJ, Rudge CJ, et al. Human leukocyte antigen and the allocation of kidneys from cadaver donors in the United Kingdom. Transplantation 2004; 77: 618.
33. Taylor CJ, Smith SI, Morgan CH, et al. Selective omission of the donor cross-match before renal transplantation: Efficacy, safety and effects on cold storage time, Transplantation 2000; 69: 719.
34. Gebel HM, Bray RA. Nickerson pre-transplant assessment of donor-reactive HLA-specific antibodies in renal transplantation. Am J Transplant 2003; 3: 1488.
35. Crew RJ, Ratner LE. Transplanting the sensitised patient. Curr Opin Organ Transplant 2007; 12: 415.
36. Delmonico FL, Morrissey PE, Lipkowitz GS, et al. Donor kidney exchanges. Am J Transplant 2004; 4: 1628.
37. De Klerk M, Keizer KM, Claas FHJ, et al. The Dutch national living donor kidney exchange program. Am J Transplant 2005; 5: 2302.
38. Montgomery RA, Gentry SE, Marks WH, et al. Domino paired kidney donation: A strategy to make best use of live non-directed donation. Lancet 2006; 368: 419.
39. Muro M, Llorente S, Marin L, et al. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: Discrepancies between FlowPRA™, ELISA and CDC vs luminex screening. Nephrol Dial Transplant 2005; 20: 223.
40. Zachary AA, Montgomery RA, Ratner LE, et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003; 76: 1519.
41. Glotz D, Antoine C, Duboust A. Antidonor antibodies and transplantation: How to deal with them before and after transplantation. Transplantation 2005; 79: S30.
42. Warren DS. Simpkins CE. Cooper M. Montgomery RA. Modulating alloimmune responses with plasmapheresis and IVIG. Curr Drug Targets Cardiovas Haematol Disord 2005; 5: 215.